We're excited to announce that we have joined our RTI Health Solutions colleagues under the RTI Health Solutions brand. Offering our clients a complete perspective from all healthcare stakeholders, our unity reflects RTI’s unwavering commitment to improving the human condition.
If you are attending #ICPE23, visit us at booth #1000, chat with our researchers, and scan your badge to be entered to win one of three copies of Modern Epidemiology: 4th Edition, coauthored by RTI Health Solutions expert Kenneth Rothman. https://t.co/JTYEEJ0Dh8
Did you know ISPOR has year-round educational learning opportunities? From our conferences to webinars, summits, short courses, roundtables, and more, there is a learning format for everyone. View our upcoming events and ramp up your #HEOR knowledge! https://t.co/ktlTq1tZqC
We are ONE MONTH away from the much-anticipated #ICPE23 in Halifax! Who all are we going to see there? Comment below with "I'm attending!" if you're going to be there August 23-27.
#PharmEpi#EpiTwitter#Pharmacoepidemiology
Medtech companies - looking for budget-friendly value assessment & evidence gap analysis? RTI-HS is a certified NICE META tool facilitator. Let's see if this tool is right for your product. https://t.co/S1N0wWEYkZ #digitalhealth
Looking for a team with proven performance, adherence to ISPOR and WHO best practices, and a wide range of experience to assist you with #infectiousdisease modeling? Take a look at our qualifications. https://t.co/YScSJZObIu
Cigna has selected RTI for their 2023 silver level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and well-being of its employees. https://t.co/0Ia3FmgF0o #EPIjobs
-How HRQOL data analysis pooled across multiple trials demonstrated extended time to deterioration in quality of life for oncology product. Read the case study->https://t.co/uOpYg67UZT #biostatistics
Challenged with developing pre-approval information exchange (PIE) materials? We can help you communicate key pre-approval information about your medtech or #drugdevelopment. https://t.co/o95M7tszvd #GVD
We can help you identify potential gaps in your evidence and create a plan to address them—saving you time and costly re-work down the road. https://t.co/Wwblye9zlI #pharma#CRO#drugresearch
Have you seen our case study on determining the long-term benefits of a therapy slowing kidney function decline without long-term clinical trials? Read it here->https://t.co/jijPfoELfY #kidneyresearch#kidneyfunction
Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in Rare Disease and #GeneTherapy. Learn more https://t.co/0kCNjxwQ2H @DrugInfoAssn#RWD#RWE#pharma
Our approach to providing analysis results in a consistent format across trials allows clients to easily incorporate results in reports, submissions, and publications. https://t.co/KfqGjcigqB #HTA#pharmaceutical
Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in #RareDisease and Gene Therapy. Learn more https://t.co/0kCNjxwQ2H @DrugInfoAssn#biotech @pregnancyresearch
Research we've coauthored, Preferences for oral antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. https://t.co/3cM2PLCKMs @ISBD4
Research we've coauthored, Preferences for oral #antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. https://t.co/3cM2PLCKMs @ISBD4#BipolarResearch
🏳🌈 This month, RTI is honoring #Pride2023 by celebrating our Pride Employee Resource Group (ERG). Join us as we listen to our members sharing their experiences at RTI & discussing their motivations for joining. Part 2 we spoke with Public Health Analyst, Maggie Rothenberg👇